OCGN - Ocugen, Inc.
IEX Last Trade
0.7459
0.009 1.233%
Share volume: 155,031
Last Updated: Mon 13 Jan 2025 08:29:25 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.44%
PREVIOUS CLOSE
CHG
CHG%
$0.74
0.01
1.25%
Summary score
9%
Profitability
8%
Dept financing
8%
Liquidity
49%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-110.51%
Return on assets
-18.64%
Return on sales
-1848.38%
Return on invested capital
261.7%
Total debt ratio
25.94%
Debt ratio change over timeo
-0.89%
Current Ratio
6.06%
Quick Ratio
0%
Cash Position Ratio
5.5%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-20.26%
Return on sales
-1545.6%
Return on invested capital
0%
Total debt ratio
31.19%
Debt ratio change over timeo
-0.88%
Current Ratio
3.5%
Quick Ratio
0%
Cash Position Ratio
3.29%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-23.59%
Return on sales
-1204.73%
Return on invested capital
0%
Total debt ratio
41.58%
Debt ratio change over time
-0.84%
Current Ratio
1.87%
Quick Ratio
0%
Cash Position Ratio
1.64%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-166.24%
Return on assets
-107.34%
Return on sales
-806.3%
Return on invested capital
56.85%
Total debt ratio
-89.33%
Debt ratio change over time
-0.89%
Current Ratio
1.38%
Quick Ratio
0%
Cash Position Ratio
1.14%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | OCGN | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | -110.51% | 13.03% | 18.15% | 6.63% |
| Return on assets | -18.64% | 2.28% | 3.22% | 5.84% |
| Return on sales | -1848.38% | 27.95% | 31.46% | 43.41% |
| Return on invested capital | 261.7% | 2.07% | 5.53% | 34.89% |
| Profitability | 25% | 44% | 57% | 62% |
| Total debt ratio | 25.94% | 91.02% | 90.77% | 24.67% |
| Debt ratio change over time | -0.89% | 435.59% | 17.23% | -0.06% |
| Dept financing | 7% | 50% | 26% | 7% |
| Current Ratio | 3.5% | 0.82% | 1.41% | 3.64% |
| Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
| Cash Position Ratio | 3.29% | 0.31% | 0.49% | 2.77% |
| Liquididy | 50% | 10% | 21% | 57% |
| Short-term ratios | OCGN | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 5.91% |
| Return on assets | -20.26% | 1.6% | 2.14% | 4.97% |
| Return on sales | -1545.6% | 24.8% | 18.91% | 42.59% |
| Return on invested capital | 0% | 0% | 0% | 23.7% |
| Profitability | 0% | 23% | 22% | 100% |
| Total debt ratio | 31.19% | 94.49% | 93.35% | 24.56% |
| Debt ratio change over time | -0.88% | 0% | 0% | -0.62% |
| Dept financing | 8% | 25% | 50% | 6% |
| Current Ratio | 3.5% | 0.82% | 1.41% | 3.64% |
| Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
| Cash Position Ratio | 3.29% | 0.31% | 0.49% | 2.77% |
| Liquididy | 49% | 13% | 21% | 71% |